Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/136307
Author(s): Salehi, B
Sestito, S
Rapposelli, S
Peron, G
Calina, D
Sharifi-Rad, M
Sharopov, F
Martins, N
Sharifi-Rad, J
Title: Epibatidine: A promising natural alkaloid in health
Publisher: MDPI
Issue Date: 2019
Abstract: Epibatidine is a natural alkaloid that acts at nicotinic acetylcholine receptors (nAChRs). The present review aims to carefully discuss the affinity of epibatidine and its synthetic derivatives, analogues to nAChRs for a4ß2 subtype, pharmacokinetic parameters, and its role in health. Published literature shows a low affinity and lack of binding of epibatidine and its synthetic analogues to plasma proteins, indicating their availability for metabolism. Because of its high toxicity, the therapeutic use of epibatidine is hampered. However, new synthetic analogs endowed from this molecule have been developed, with a better therapeutic window and improved selectivity. All these aspects are also discussed here. On the other hand, many reports are devoted to structure–activity relationships to obtain optically active epibatidine and its analogues, and to access its pharmacological effects. Although pharmacological results are obtained from experimental studies and only a few clinical trials, new perspectives are open for the discovery of new drug therapies.
Subject: ABT-418
ABT-594
Analgesics
Epibatidine
Nicotinic acetylcholine receptors
DOI: 10.3390/biom9010006
URI: https://hdl.handle.net/10216/136307
Source: Biomolecules, vol.9(1):6
Related Information: info:eu-repo/grantAgreement/FCT/5876/147342/PT
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
License: https://creativecommons.org/licenses/by/4.0/
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-biom9010006.pdf705.49 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons